Priyatansh Gurha1, Xiaofan Chen1, Raffaella Lombardi1, James T Willerson1, Ali J Marian2. 1. From the Center for Cardiovascular Genetics, Institute of Molecular Medicine and Department of Medicine, University of Texas Health Sciences Center at Houston, and Texas Heart Institute. 2. From the Center for Cardiovascular Genetics, Institute of Molecular Medicine and Department of Medicine, University of Texas Health Sciences Center at Houston, and Texas Heart Institute. Ali.J.Marian@uth.tmc.edu Priyatansh.Gurha@uth.tmc.edu.
Abstract
RATIONALE: PKP2, encoding plakophilin 2 (PKP2), is the most common causal gene for arrhythmogenic cardiomyopathy. OBJECTIVE: To characterize miRNA expression profile in PKP2-deficient cells. METHODS AND RESULTS: Control and PKP2-knockdown HL-1 (HL-1(Pkp2-shRNA)) cells were screened for 750 miRNAs using low-density microfluidic panels. Fifty-nine miRNAs were differentially expressed. MiR-184 was the most downregulated miRNA. Expression of miR-184 in the heart and cardiac myocyte was developmentally downregulated and was low in mature myocytes. MicroRNA-184 was predominantly expressed in cardiac mesenchymal progenitor cells. Knockdown of Pkp2 in cardiac mesenchymal progenitor cells also reduced miR-184 levels. Expression of miR-184 was transcriptionally regulated by the E2F1 pathway, which was suppressed in PKP2-deficient cells. Activation of E2F1, on overexpression of its activator CCND1 (cyclin D1) or knockdown of its inhibitor retinoblastoma 1, partially rescued miR-184 levels. In addition, DNA methyltransferase-1 was recruited to the promoter region of miR-184, and the CpG sites at the upstream region of miR-184 were hypermethylated. Treatment with 5-aza-2'-deoxycytidine, a demethylation agent, and knockdown of DNA methyltransferase-1 partially rescued miR-184 level. Pathway analysis of paired miR-184:mRNA targets identified cell proliferation, differentiation, and death as the main affected biological processes. Knockdown of miR-184 in HL-1 cells and mesenchymal progenitor cells induced and, conversely, its overexpression attenuated adipogenesis. CONCLUSIONS: PKP2 deficiency leads to suppression of the E2F1 pathway and hypermethylation of the CpG sites at miR-184 promoter, resulting in downregulation of miR-184 levels. Suppression of miR-184 enhances and its activation attenuates adipogenesis in vitro. Thus, miR-184 contributes to the pathogenesis of adipogenesis in PKP2-deficient cells.
RATIONALE: PKP2, encoding plakophilin 2 (PKP2), is the most common causal gene for arrhythmogenic cardiomyopathy. OBJECTIVE: To characterize miRNA expression profile in PKP2-deficient cells. METHODS AND RESULTS: Control and PKP2-knockdown HL-1 (HL-1(Pkp2-shRNA)) cells were screened for 750 miRNAs using low-density microfluidic panels. Fifty-nine miRNAs were differentially expressed. MiR-184 was the most downregulated miRNA. Expression of miR-184 in the heart and cardiac myocyte was developmentally downregulated and was low in mature myocytes. MicroRNA-184 was predominantly expressed in cardiac mesenchymal progenitor cells. Knockdown of Pkp2 in cardiac mesenchymal progenitor cells also reduced miR-184 levels. Expression of miR-184 was transcriptionally regulated by the E2F1 pathway, which was suppressed in PKP2-deficient cells. Activation of E2F1, on overexpression of its activator CCND1 (cyclin D1) or knockdown of its inhibitor retinoblastoma 1, partially rescued miR-184 levels. In addition, DNA methyltransferase-1 was recruited to the promoter region of miR-184, and the CpG sites at the upstream region of miR-184 were hypermethylated. Treatment with 5-aza-2'-deoxycytidine, a demethylation agent, and knockdown of DNA methyltransferase-1 partially rescued miR-184 level. Pathway analysis of paired miR-184:mRNA targets identified cell proliferation, differentiation, and death as the main affected biological processes. Knockdown of miR-184 in HL-1 cells and mesenchymal progenitor cells induced and, conversely, its overexpression attenuated adipogenesis. CONCLUSIONS:PKP2 deficiency leads to suppression of the E2F1 pathway and hypermethylation of the CpG sites at miR-184 promoter, resulting in downregulation of miR-184 levels. Suppression of miR-184 enhances and its activation attenuates adipogenesis in vitro. Thus, miR-184 contributes to the pathogenesis of adipogenesis in PKP2-deficient cells.
Authors: Eduardo Garcia-Gras; Raffaella Lombardi; Michael J Giocondo; James T Willerson; Michael D Schneider; Dirar S Khoury; Ali J Marian Journal: J Clin Invest Date: 2006-07 Impact factor: 14.808
Authors: Brenda Gerull; Arnd Heuser; Thomas Wichter; Matthias Paul; Craig T Basson; Deborah A McDermott; Bruce B Lerman; Steve M Markowitz; Patrick T Ellinor; Calum A MacRae; Stefan Peters; Katja S Grossmann; Jörg Drenckhahn; Beate Michely; Sabine Sasse-Klaassen; Walter Birchmeier; Rainer Dietz; Günter Breithardt; Eric Schulze-Bahr; Ludwig Thierfelder Journal: Nat Genet Date: 2004-10-17 Impact factor: 38.330
Authors: Raffaella Lombardi; Suet Nee Chen; Alessandra Ruggiero; Priyatansh Gurha; Grazyna Z Czernuszewicz; James T Willerson; Ali J Marian Journal: Circ Res Date: 2016-04-27 Impact factor: 17.367
Authors: Tung-Ying Lu; Bo Lin; Yang Li; Arshi Arora; Lu Han; Cheng Cui; Claudia Coronnello; Yi Sheng; Panayiotis V Benos; Lei Yang Journal: J Mol Cell Cardiol Date: 2013-08-09 Impact factor: 5.000
Authors: Alessandra Castaldi; Tania Zaglia; Vittoria Di Mauro; Pierluigi Carullo; Giacomo Viggiani; Giulia Borile; Barbara Di Stefano; Gabriele Giacomo Schiattarella; Maria Giovanna Gualazzi; Leonardo Elia; Giuliano Giuseppe Stirparo; Maria Luisa Colorito; Gianluigi Pironti; Paolo Kunderfranco; Giovanni Esposito; Marie-Louise Bang; Marco Mongillo; Gianluigi Condorelli; Daniele Catalucci Journal: Circ Res Date: 2014-05-07 Impact factor: 17.367
Authors: Suet Nee Chen; Raffaella Lombardi; Jennifer Karmouch; Ju-Yun Tsai; Grace Czernuszewicz; Matthew R G Taylor; Luisa Mestroni; Cristian Coarfa; Priyatansh Gurha; Ali J Marian Journal: Circ Res Date: 2019-03-15 Impact factor: 17.367
Authors: Sirisha M Cheedipudi; Scot J Matkovich; Cristian Coarfa; Xin Hu; Matthew J Robertson; Mary Sweet; Matthew Taylor; Luisa Mestroni; Joseph Cleveland; James T Willerson; Priyatansh Gurha; Ali J Marian Journal: Circ Res Date: 2019-04-12 Impact factor: 17.367
Authors: Gaelle Auguste; Priyatansh Gurha; Raffaella Lombardi; Cristian Coarfa; James T Willerson; Ali J Marian Journal: Circ Res Date: 2018-01-09 Impact factor: 17.367
Authors: Sirisha M Cheedipudi; Jinzhu Hu; Siyang Fan; Ping Yuan; Jennifer Karmouch; Grace Czernuszewicz; Matthew J Robertson; Cristian Coarfa; Kui Hong; Yan Yao; Hanna Campbell; Xander Wehrens; Priyatansh Gurha; Ali J Marian Journal: Cardiovasc Res Date: 2020-05-01 Impact factor: 10.787
Authors: Jennifer Karmouch; Qiong Q Zhou; Christina Y Miyake; Raffaella Lombardi; Kai Kretzschmar; Marie Bannier-Hélaouët; Hans Clevers; Xander H T Wehrens; James T Willerson; Ali J Marian Journal: Circ Res Date: 2017-10-10 Impact factor: 17.367
Authors: Karyn M Austin; Michael A Trembley; Stephanie F Chandler; Stephen P Sanders; Jeffrey E Saffitz; Dominic J Abrams; William T Pu Journal: Nat Rev Cardiol Date: 2019-09 Impact factor: 32.419
Authors: Quincy A Hathaway; Mark V Pinti; Andrya J Durr; Shanawar Waris; Danielle L Shepherd; John M Hollander Journal: Am J Physiol Heart Circ Physiol Date: 2017-10-06 Impact factor: 4.733